Jakemans Throat and Chest Honey and Lemon

Description

JAKEMANS is a menthol cough suppressant and oral anesthetic formulated to provide relief for throat and chest discomfort. Established in 1907, this product has been manufactured in Boston, England, for over a century, utilizing the finest natural ingredients. Each package contains 24 lozenges, which are flavored with honey and lemon, along with other natural flavors, to enhance the user experience.

Uses and Indications

This drug is indicated for the treatment of persistent or chronic cough associated with smoking, asthma, or emphysema. It is also indicated for cough that occurs with excessive phlegm (mucus).

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is recommended to consult a doctor before administration.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Patients should be advised of the potential for a sore throat as a warning sign. In instances where the sore throat is severe, persists for more than two days, or is accompanied by additional symptoms such as fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly for further evaluation and management.

Healthcare providers should remain vigilant in monitoring patients for these symptoms to ensure timely intervention and to mitigate any potential complications.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. A notable warning includes the potential for a severe sore throat. If patients experience a sore throat that is severe, persists for more than 2 days, or is accompanied or followed by symptoms such as fever, headache, rash, swelling, nausea, or vomiting, it is imperative that they consult a healthcare professional promptly.

Monitoring for these symptoms is essential to ensure timely medical intervention and to mitigate any potential complications.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Jakemans Throat and Chest Honey and Lemon (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the lozenge should be dissolved slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a healthcare provider.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Serious adverse events have been reported voluntarily or through surveillance programs. Healthcare professionals and patients are encouraged to report any serious adverse events to the designated contact number: 1-866-205-1185.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young children.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring it is kept in a cool, dry place to maintain its integrity. The product must be protected from light exposure to prevent degradation. Freezing is not permitted, as it may compromise the quality of the product. Once opened, any unused portion should be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered orally, with adults and children aged 2 years and older instructed to dissolve the lozenge slowly in the mouth. Dosing may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, consultation with a doctor is recommended prior to use.

Clinicians are advised to report any serious adverse events associated with the medication by calling 1-866-205-1185. No additional information is available regarding laboratory tests, abuse potential, or patient counseling.

Drug Information (PDF)

This file contains official product information for Jakemans Throat and Chest Honey and Lemon, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)